Skip to main content

Typical Versus Atypical Carcinoid and Diffuse Idiopathic Neuroendocrine Cell Hyperplasia Versus Carcinoid Tumorlets

  • Chapter
  • First Online:
Practical Lung Pathology

Part of the book series: Practical Anatomic Pathology ((PAP))

  • 598 Accesses

Abstract

Carcinoid tumors of the lung are primary pulmonary neoplasms which typically occur in middle-aged individuals. The most common presentations are persistent cough, possibly with hemoptysis, or recurrent episodes of pneumonia. Pulmonary carcinoid tumors occur as either low-grade typical carcinoid (TC) or more aggressive intermediate-grade atypical carcinoid (AC). Histologically, both are characterized by nests of neuroendocrine cells arising from neuroendocrine cells of the airway epithelium. The atypical form is defined by the presence of either punctate necrosis or a mitotic rate from 2 to 10 mitotic figures/2 mm2; they are associated with more aggressive behavior and lower overall rates of survival when compared to TC.

Diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and carcinoid tumorlets are two forms of neuroendocrine cell hyperplasia that affect predominantly women in their 50s and 60s. Both entities will present with multiple pulmonary nodules. In DIPNECH, multiple small nodules are seen bilaterally, commonly showing a linear pattern along bronchi and bronchioles on radiographic imaging, whereas tumorlets are small (≤5 mm) localized lesions associated with underlying primary lung disease.

All these entities demonstrate similar immunohistochemical profiles, with positivity for neuroendocrine markers and variable expression of TTF-1. As such, their differentiation is based largely on their morphologic features in conjunction with both clinical and radiographic correlation. This is particularly true in making the diagnosis of DIPNECH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Linnoila RI. Functional facets of the pulmonary neuroendocrine system. Lab Investig. 2006;86(5):425–44.

    Article  CAS  PubMed  Google Scholar 

  2. Rekhtman N. Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med. 2010;134(11):1628–38.

    Article  PubMed  Google Scholar 

  3. Mengoli MC, Rossi G, Cavazza A, Franco R, Marino FZ, Migaldi M, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) syndrome and carcinoid tumors with/without NECH: a clinicopathologic, radiologic, and Immunomolecular comparison study. Am J Surg Pathol. 2018;42(5):646–55.

    Article  PubMed  Google Scholar 

  4. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60.

    Article  PubMed  Google Scholar 

  5. Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13(12):1255–69.

    Article  CAS  PubMed  Google Scholar 

  6. Koo CW, Baliff JP, Torigian DA, Litzky LA, Gefter WB, Akers SR. Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids. AJR Am J Roentgenol. 2010;195(3):661–8.

    Article  PubMed  Google Scholar 

  7. Dincer HE, Podgaetz E, Andrade RS. Pulmonary neuroendocrine tumors: Part I. Spectrum and characteristics of tumors. J Bronchology Interv Pulmonol. 2015;22:267–73.

    Article  PubMed  Google Scholar 

  8. Sheppard MN. Nuclear pleomorphism in typical carcinoid tumours of the lung: problems in frozen section interpretation. Histopathology. 1997;30(5):478–80.

    Article  CAS  PubMed  Google Scholar 

  9. Marchevsky AM, Hendifar A, Walts AE. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence. Mod Pathol. 2018;31(10):1523–31.

    Article  PubMed  Google Scholar 

  10. Pelosi G, Rindi G, Travis WD, Papotti M. Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice. J Thorac Oncol. 2014;9(3):273–84.

    Article  CAS  PubMed  Google Scholar 

  11. García-Yuste M, Matilla JM. The significance of histology: typical and atypical bronchial carcinoids. Thorac Surg Clin. 2014;24(3):293–7.

    Article  PubMed  Google Scholar 

  12. Rossi G, Cavazza A, Spagnolo P, Sverzellati N, Longo L, Jukna A, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. Eur Respir J. 2016;47(6):1829–41.

    Article  CAS  PubMed  Google Scholar 

  13. Davies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax. 2007;62(3):248–52.

    Article  PubMed  Google Scholar 

  14. Gorshtein A, Gross DJ, Barak D, Strenov Y, Refaeli Y, Shimon I, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors. Cancer. 2012;118(3):612–9.

    Article  PubMed  Google Scholar 

  15. Marchevsky AM, Wirtschafter E, Walts AE. The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH? Human Patholol. 2015;46(2):176–81.

    Article  CAS  Google Scholar 

  16. Ginsberg MS, Akin O, Berger DM, Zakowski MF, Panicek DM. Pulmonary Tumorlets: CT findings. Am J Roentgenol. 2004;183(2):293–6.

    Article  Google Scholar 

  17. Kallianos A, Velentza L, Zarogoulidis P, Baka S, Kosmidis C, Labaki S, et al. Progressive dyspnea due to pulmonary carcinoid tumorlets. Respir Med Case Rep. 2017;6(21):84–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Haodong Xu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morse, R.J., Xu, H. (2022). Typical Versus Atypical Carcinoid and Diffuse Idiopathic Neuroendocrine Cell Hyperplasia Versus Carcinoid Tumorlets. In: Xu, H., Ricciotti, R.W., Mantilla, J.G. (eds) Practical Lung Pathology. Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-14402-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-14402-8_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-14401-1

  • Online ISBN: 978-3-031-14402-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics